concizumab sold brand name alhemo monoclonal antibody used treatment hemophilia antitissue factor pathway concizumab approved medical use canada march concizumab indicated treatment people hemophilia b factor ix inhibitors require routine prophylaxis prevent reduce frequency bleeding concizumab international nonproprietary pharmacologyrelated article stub help wikipedia expanding ithttpsenwikipediaorgwikiconcizumab